Ryan Pawell Talks About Indee Labs’ CRISPR Delivery Technology for Affordable Immunotherapies

CRISPR Cuts

English - May 07, 2020 12:00 - 12 minutes - 11.9 MB - ★★★★★ - 31 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Making of a CRISPR Film: Behind the Scenes with Producers of Human Nature

Next Episode: CRISPR Office Hours with Hamid Ghanadaan

The mission of Indee Labs, a Berkeley biotech, is to deliver CRISPR reagents into cells using microfluidics for developing affordable cell and gene therapies in the future. We interviewed Ryan Pawell, Founder and CEO of Indee Labs, about the concept of using microfluidics for CRISPR delivery, their mission and ongoing projects, and the convergence of engineering and biology for building scalable platforms.